Group B Streptococcal Infections in Newborns
What is group B streptococcal infection?
Group B streptococcal (group B strep) infection is a serious bacterial infection that is a leading cause of death and disability in newborns.
In the 1970s, about half of newborns with group B strep infection died. Today, due to early recognition and aggressive treatment of the infection, far fewer cases end in death.
What causes group B streptococcal infection?
Group B strep bacteria normally exist in the intestine, vagina, or rectum. A pregnant woman can transmit the bacteria to her fetus during delivery. Some women are carriers of group B streptococcal bacteria, which means that they carry the bacteria but have no illness from it. It is unclear why some babies get group B strep infection and others do not.
Newborns may develop the infection hours after birth or during the first week of life, or it may happen several months later. Newborns who develop group B strep within the first week are most always infected by their mothers. It's not clear how babies who develop the infection later are exposed to the bacteria.
What are the symptoms?
Newborns infected with group B strep within the first 6 days of life may get a blood infection (sepsis) or lung infection (pneumonia). Symptoms of late-stage group B strep (7 days to 3 months of age) may include high or low body temperature, irritability, low energy, raised respiratory rate, and trouble feeding. An infection of the fluid or tissues that surround the brain and spinal cord (meningitis) could occur in the early or late stage. Newborns thought to be infected with group B strep need medical care right away, as the infection can be deadly.
How is group B streptococcal infection diagnosed?
Guidelines suggest that all pregnant women have prenatal testing (rectal and vaginal cultures) for group B strep between 35 to 37 weeks of pregnancy.1 Babies suspected of being infected are diagnosed at birth by testing their blood or spinal fluid or both for group B strep bacteria.
How is it treated?
Pregnant women with group B strep infection or who are carriers of group B strep will be given antibiotics prior to delivery to prevent transmission of the bacteria to the newborn during delivery. Women who are pregnant and who have previously given birth to a child with group B strep infection, or who have had tests that show they carry the bacteria, should be treated with antibiotics.
Newborns with the infection will also be given antibiotics. In addition to antibiotics, supportive care including fluids and ventilation will be given if needed. In some cases, a doctor will treat a newborn that is suspected of having group B strep infection before test results have shown infection. This is because not treating strep B infection in newborns can result in illness or death.
Having a baby by cesarean section does not prevent the transmission of group B strep bacteria.
Other Places To Get Help
|Centers for Disease Control and Prevention (CDC)|
|1600 Clifton Road|
|Atlanta, GA 30333|
The Centers for Disease Control and Prevention (CDC) is an agency of the U.S. Department of Health and Human Services. The CDC works with state and local health officials and the public to achieve better health for all people. The CDC creates the expertise, information, and tools that people and communities need to protect their health—by promoting health, preventing disease, injury, and disability, and being prepared for new health threats.
|National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health|
|NIAID Office of Communications and Public Liaison|
|6610 Rockledge Drive, MSC 6612|
|Bethesda, MD 20892-6612|
The National Institute of Allergy and Infectious Diseases conducts research and provides consumer information on infectious and immune-system-related diseases.
- Schrag S, et al. (2002). Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC. MMWR, 51(RR-11): 1–22.
Other Works Consulted
- American Academy of Pediatrics (2006). Group B streptococcal infections. In LK Pickering et al., eds., Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed., pp. 620–627. Elk Grove Village, IL: American Academy of Pediatrics.
|Author||Debby Golonka, MPH|
|Editor||Susan Van Houten, RN, BSN, MBA|
|Associate Editor||Pat Truman, MATC|
|Primary Medical Reviewer||Michael J. Sexton, MD - Pediatrics|
|Specialist Medical Reviewer||Jennifer Merchant, MD - Neonatal-Perinatal Medicine|
|Last Updated||May 5, 2009|
Last Updated: May 5, 2009
Author: Debby Golonka, MPH